Evolocumab, a PCSK9‐Monoclonal Antibody, Rapidly Reverses Coronary Artery Endothelial Dysfunction in People Living With HIV and People With Dyslipidemia

BACKGROUND: PCSK9 (proprotein convertase subtilisin/kexin type 9) is well recognized for its important role in cholesterol metabolism. Elevated levels are associated with increased cardiovascular risk and inhibition with PCSK9 antibodies (PCSK9i) lowers cardiovascular events in patients with coronar...

Descripción completa

Detalles Bibliográficos
Autores principales: Leucker, Thorsten M., Gerstenblith, Gary, Schär, Michael, Brown, Todd T., Jones, Steven R., Afework, Yohannes, Weiss, Robert G., Hays, Allison G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Brief Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7660736/
https://www.ncbi.nlm.nih.gov/pubmed/32674634
http://dx.doi.org/10.1161/JAHA.120.016263

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7660736/
https://www.ncbi.nlm.nih.gov/pubmed/32674634
http://dx.doi.org/10.1161/JAHA.120.016263

Ejemplares similares